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Redox chemistry of the molecular interactions
between tea catechins and human serum proteins
under simulated hyperglycemic conditions
Hazal Özyurt,a Carolina Lunab and Mario Estévez*c
Carbonylation is an irreversible modification in oxidized proteins that has been directly related to a
number of health disorders including Type 2 diabetes. Dietary antioxidants have been proposed to coun-
teract the oxidative stress occurring under hyperglycemic conditions. An understanding of the nature and
consequences of the molecular interactions between phytochemicals and human plasma proteins is of
utmost scientific interest. Three tea catechins namely epicatechin (EC), epigallocatechin (EGC) and epigal-
locatechin-3-gallate (EGCG) were tested for (i) their affinity to bind to human serum albumin (HSA) and
human hemoglobin (HH) and (ii) their ability to inhibit tryptophan (Trp) depletion and for the formation of
specific protein carbonyls and pentosidine in the aforementioned proteins. Both proteins (20 mg mL−1)
were allowed to react with postprandial plasmatic concentrations of the catechins (EC: 0.7 µM, EGC:
1.8 µM, and EGCG: 0.7 µM) under simulated hyperglycemic conditions (12 mM glucose/0.2 mM Fe3+/
37 °C/10 days). The three catechins were able to inhibit Trp oxidation and protein carbonylation in both
plasma proteins. Some anti-glycation properties were linked to their binding affinities. The molecular
interactions reported in the present study may explain the alleged beneficial effects of tea catechins
against the redox impairment linked to hyperglycemic conditions.
1. Introduction
Protein oxidative modifications are a major class of protein
post-translational changes and contribute to cell dysfunction
and human disease.1,2 Carbonylation is an irreversible modifi-
cation in oxidized proteins that has been directly related to a
number of health disorders.3 Carbonyls can be formed in pro-
teins by three different pathways: (i) radical-mediated oxi-
dation of the side chains of alkaline amino acids such as
lysine, threonine, arginine and proline; (ii) the reaction of the
δ-amino group of an alkaline amino acid with reducing sugars
or their oxidation products and (iii) the oxidative cleavage of
the peptide backbone via the α-amidation pathway or the oxi-
dation of glutamyl side chains.4 Among the three mechanisms,
the Maillard-mediated reaction has been reported to be a sig-
nificant carbonylation pathway in muscle and plasma
proteins.5,6
The Maillard reaction occurs between amino groups in pro-
teins and a reducing sugar such as glucose and leads to the
formation of multiple products including Schiff bases,
Amadori products and advanced glycation end products
(AGEs).7 The discovery that specific markers of oxidative stress
such as protein carbonyls, α-aminoadipic semialdehyde and
γ-glutamic semialdehyde (AAS and GGS, respectively) are also
formed in the presence of reducing sugars5,6 exemplifies the
interconnections between protein glycation and protein oxi-
dation already highlighted by Wolff et al.8 Akagawa et al.9
identified the Maillard reaction as responsible for the accumu-
lation of AAS and GGS in plasma proteins from diabetic rats.
The detection of post-translational changes in plasma proteins
as a result of pathological conditions by using such specific
markers is of indisputable interest for diagnosis and health
control purposes. Carbonylation in particular is known to
occur in plasma proteins of Type II diabetic patients with this
oxidative damage being the cause of subsequent functional
impairments.3,10 Little is known, however, about the formation
of these particular protein carbonyls in human proteins under
physiological and/or pathological conditions and the suit-
ability of using these compounds as specific markers of glyco-
sylation and disease.
Polyphenols have been attributed with diverse bioactivities
as they act as free radical scavengers, metal chelators, enzy-
matic activity modulators, signal transductors and gene
expression activators.11 Owing to their versatile biological func-
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tions, these compounds have been proposed for the treatment
of chronic disorders, such as Type II diabetes, heart diseases
and various types of cancer.11 Tea is an excellent source of
polyphenols with (−)-epicatechin (EC), (−)-epicatechin gallate
(ECG), (−)-epigallocatechin (EGC), and (−)-epigallocatechin-3-
gallate (EGCG) being the most abundant.12 These species have
displayed many pharmacological effects such as antimuta-
genic, antiproliferative, anticarcinogenic and neuroprotective
activities.13 Interestingly, EC, EGC and EGCG occur in the
blood of human individuals after tea consumption at concen-
trations ranging from 78 to 550 ng mL−1.14,15 While the
binding affinities and molecular interactions between tea poly-
phenols and plasma proteins have been studied,16,17 the
effects of these phytochemicals against the damage caused by
oxidative stress and glycosylation to human proteins are
mostly unknown.
The objective of this study was to evaluate the effectiveness
of the three major tea polyphenols, namely EC, EGC and
EGCG, against the carbonylation of human plasma proteins
(human serum albumin and hemoglobin) under simulated
pathological concentrations of glucose.
2. Material and methods
2.1. Chemicals
EGCG and EGC were purchased from HWI Analytik GMBH
(Rülzheim, Germany). EC, albumin from human serum (HSA),
human hemoglobin (HH), sodium cyanoborohydride
(NaCNBH3), diethylenetriaminepentaacetic acid (DTPA),
1,1-diphenyl-2-picrylhydrazyl (DPPH), sodium dodecyl sulfate
(SDS), 4-aminobenzoic acid (ABA), 2-(N-morpholino)ethane-
sulfonic acid (MES) monohydrate and iron(III) chloride reagent
grade were acquired from Sigma-Aldrich Co. Ltd (Steinheim,
Germany). D(+)-Glucose monohydrate, sodium dihydrogen
phosphate (NaH2PO4), di-sodium hydrogen phosphate
(Na2HPO4), trichloroacetic acid (TCA), sodium acetate an-
hydrous, methanol, acetonitrile, diethylether, ethanol and
hydrochloric acid were obtained from Scharlau Labs S.L.
(Barcelona, Spain). Water used was purified by passage
through a Milli-Q system (Millipore Corp., Bedford, MA).
Solutions were freshly prepared prior to use.
2.2. Assay of binding affinity between human plasma
proteins and catechins
For a detailed study of catechin–protein interactions, the
quenching of protein intrinsic (tryptophan) fluorescence by
the phenolics was employed as follows. HSA and HH
(20 mg mL−1) were dissolved in sodium phosphate buffer
(pH 7.4; 100 mM). Individual phenolics (EC, EGC, EGCG) were
dissolved in aqueous methanol (20%) in order to yield
0.87 mM, 1 mM, 1.3 mM stock solutions, respectively.
Fluorescence spectra were recorded on a Perkin Elmer LS 55
luminescence spectrometer (Perkin Elmer, Cambridge, UK)
using a 10 mm quartz Suprasil fluorescence cuvette (Hellma,
Germany). In order to quantify the potential interaction
between catechins and human proteins, the latter were titrated
in a cuvette by successive additions of individual catechin solu-
tions (EC, 0.7–5.6 µM; EGC, 1.8–14.4 µM; EGCG, 0.7–5.6 µM;
final concentrations). This range of concentrations was
selected based on the data available in the literature14,15 and
on preliminary trials aimed to perceive the detectable quench-
ing of trp fluorescence in the selected proteins. Fluorescence
emission spectra were recorded from 300 to 400 nm with
excitation at 280 nm. The excitation and emission slits were
both set to 10 nm and the scanning speed was 500 nm min−1.
All experiments were carried out at 37 °C. Fluorescence inten-
sity was read at a protein emission maximum of 335 nm.
Fluorescence spectra of individual catechins at equal concen-
trations were recorded as blanks under the same experimental
conditions and subtracted from the corresponding sample to
correct the fluorescence background. The bimolecular quench-
ing rate constant (Kq) was calculated using the Stern–Volmer
equation18
F0=F ¼ 1þ Kqτ0½Q
where F0 and F are the fluorescence intensities of the protein
solutions in the absence and presence of the quencher,
respectively; [Q] is the quencher concentration, and τ0 (≈ 5 ×
109 s) is the lifetime of the fluorophore in the absence of the
quencher.18
The apparent binding constants (Kb) were calculated using
the following equation:19
logðF0  FÞ=F ¼ nlog Kb  nlogð1=ð½QF0  F½P=F0ÞÞ
where [P] is the total protein concentration and n the number
of binding sites.
2.3. DPPH radical scavenging activity
Catechins (EC: 0.7 µM, EGC: 1.8 µM, and EGCG: 0.7 µM; final
concentrations) were mixed with HSA (20 mg mL−1) and HH
(20 mg mL−1) solutions to obtain 11 different experimental
units including the units from the total factorial design (3 cate-
chins × 2 human proteins) and their respective controls (con-
taining each of these 5 components alone). Antioxidant
activities of the above samples were measured against the
DPPH free radical assay. Fifty μL of each sample was added to
2 mL of DPPH solution (6 × 105 M in methanol). The decrease
in absorbance at 517 nm was measured after 30 min. The
DPPH radical scavenging activity was calculated using the fol-
lowing formula:
DPPH radical scavenging activity ð%Þ
¼ ð1-Acontrol=AsampleÞ  100
where Acontrol is the absorbance of the control (containing all
reagents except the sample), and Asample is the absorbance of
the samples, both measured at 517 nm.
2.4. Experimental setting for glycosylation assay
Three different types of reaction units containing each of the
human protein solutions (20 mg mL−1) were prepared as
follows: Reaction 1 included only the human proteins (HH or
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HSA) as negative control samples (2 reaction units in total);
Reaction 2 included HH or HSA, FeCl3 (0.2 mM) and glucose
(12 mM) as positive control samples (2 reaction units in total);
Reaction 3 included HH or HSA, FeCl3 (0.2 mM), glucose
(12 mM) and each of the tea phenolics under study (0.7 µM,
EGCG; 0.7 µM, EC; 1.8 µM EGC; final concentrations) (6 reac-
tion units in total). All reaction mixtures were prepared in
triplicate (10 × 3 = 30 in total) and incubated at 37 °C for 10
days with constant stirring. Samples were taken at fixed times
(0, 3, 6, 10 days) for Reactions 1 and 2 and subsequently
analyzed for tryptophan (Trp), AGEs and specific protein
carbonyls. For Reaction 3, a single sampling was performed
after 10 days of incubation for the analysis of trp, AGEs and
specific protein carbonyls.
2.5. Tryptophan measurements
The concentration of Trp in human protein systems was
measured on a Perkin Elmer LS 55 luminescence spectrometer
(Perkin Elmer, Cambridge, UK). Human protein solutions were
diluted with 100 mM sodium phosphate buffer, pH 7.4. The
emission spectra were recorded from 300 to 400 nm with the
excitation wavelength established at 283 nm. Excitation and
emission slit widths were set at 10 nm. The Trp content was
calculated from the corresponding standard curves of HSA and
HH. Emission spectra of the sodium phosphate buffer and the
catechins were recorded under the same conditions and used
as background spectra in the pertinent samples. The
fluorescent quenching of catechins as measured in the
experiment described in section 2.2. was also taken into
consideration for accurate quantification purposes. Results are
expressed as mM trp.
2.6. Pentosidine measurements
Pentosidine was analyzed using a LS-55 Perkin-Elmer fluo-
rescence spectrometer (Perkin-Elmer, Beaconsfield, U.K.).
Prior to the analysis, human protein solutions were diluted
with 100 mM sodium phosphate buffer, pH 7.4. Pentosidine
was excited at 370 nm, and the emitted fluorescence was
recorded from 400 to 500 nm. The excitation and emission
slits were both set to 10 nm and the scanning speed was
500 nm min−1. Results are expressed as fluorescence intensity
(area units).
2.7. Synthesis of AAS and GGS standard compounds
N-Acetyl-L-AAS and N-acetyl-L-GGS were synthesized from Nα-
acetyl-L-lysine and Nα-acetyl-L-ornithine using lysyl oxidase
activity from the egg shell membrane following the procedure
described by Akagawa et al.5 Briefly, 10 mM Nα-acetyl-L-lysine
and Nα-acetyl-L-ornithine were independently incubated with
constant stirring with 5 g egg shell membrane in 50 mL of
20 mM sodium phosphate buffer, pH 9.0 at 37 °C for 24 h. The
egg shell membrane was then removed by centrifugation and
the pH of the solution was adjusted to 6.0 using 1 M HCl. The
resulting aldehydes were reductively aminated with 3 mmol
ABA in the presence of 4.5 mmol NaBH3CN at 37 °C for 2 h
with stirring. Then, ABA derivatives were hydrolyzed by 50 mL
of 12 M HCl at 110 °C for 10 h. The hydrolysates were evapor-
ated at 40 °C in vacuo to dryness using a Savant speed-vac
concentrator. The resulting AAS–ABA and GGS–ABA were puri-
fied by using silica gel column chromatography and ethyl
acetate/acetic acid/water (20 : 2 : 1, v/v/v) as the elution solvent.
The purity of the resulting solution and authenticity of the
standard compounds obtained following the aforementioned
procedures have been checked by using MS and 1H NMR.
2.8. Analysis of AAS and GGS
A 200 μL sample of the experimental units was dispensed in
2 mL screw-capped Eppendorf tubes and treated with 1 ml of
cold 10% TCA solution. Each Eppendorf was vortexed and
then proteins were precipitated with centrifugation at 5000g
for 5 min at 4 °C. The supernatant was removed, and the
resulting pellet was treated again with 1.5 mL of cold 5% TCA
solution. A new centrifugation was performed at 5000g for
5 min at 4 °C for protein precipitation. The supernatant was
removed, and then the pellets were treated with the following
freshly prepared solutions: 0.5 mL of 250 mM MES buffer pH
6.0 containing 1% SDS and 1 mM DTPA, 0.5 mL of 50 mM
ABA in 250 mM MES buffer pH 6.0, and 0.25 mL of 100 mM
NaBH3CN in 250 mM MES buffer pH 6.0. The derivatization
was completed by allowing the mixture to react at 37 °C for
90 min. The samples were stirred every 30 min. The derivatiza-
tion was stopped by adding 0.5 mL of cold 50% TCA followed
by centrifugation at 5000g for 5 min. The pellet was then
washed twice with 10% TCA and diethyl ether–ethanol (1 : 1).
Centrifugations at 5000g for 10 min were performed after each
washing step. The pellet was treated with 6 N HCl and kept in
an oven at 110 °C for 18 h until completion of hydrolysis. The
hydrolysates were dried in vacuo using a Savant speed-vac con-
centrator. Finally, the generated residue was reconstituted with
200 μL of Milli-Q water and then filtered through hydrophilic
polypropylene GH Polypro (GHP) syringe filters (0.45 μm pore
size, Pall Corporation) for HPLC analysis.
Samples were eluted in a Cosmosil 5C18-AR-II RP-HPLC
column (5 μm, 150 mm × 4.6 mm) equipped with a guard
column (10 mm × 4.6 mm) packed with the same material
(Nacalai Inc., USA). A Shimadzu ‘Prominence’ HPLC apparatus
(Shimadzu Corp., Kyoto, Japan), equipped with a quaternary
solvent delivery system (LC-20AD), a DGU-20AS online degas-
ser, a SIL-20A autosampler, a RF-10A XL fluorescence detector,
and a CBM-20A system controller, was used. Sodium acetate
buffer (50 mM, pH 5.4) (eluent A) and acetonitrile (ACN)
(eluent B) were used as eluents. A low-pressure gradient
programme was used, varying B concentration from 0%
(min 0) to 8% (min 20). The volume injection was 0.5 μL, the
flow rate was kept at 1 mL min−1, and the temperature of the
column was maintained constant at 30 °C. Excitation and
emission wavelengths were set at 283 and 350 nm, respectively.
Standards (0.2 μL) were run and analyzed under the same con-
ditions. Identification of both derivatized semialdehydes in
the FLD chromatograms was carried out by comparing their
retention times with those from the standard compounds. The
peaks corresponding to AAS–ABA and GGS–ABA were manually
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integrated from FLD chromatograms and the resulting areas
were plotted against an ABA standard curve with known con-
centrations that ranged from 0.1 to 0.5 mM. Results are
expressed as nmol of carbonyl compound per mg of protein.
3. Statistics
All experimental units were prepared in triplicate and each
individual sample at each sampling time was analyzed three
times for each measurement. The effect of the addition of the
tea catechins on the extent of Trp loss and the formation of
AGEs and protein carbonyls was analyzed by an Analysis of
Variance (ANOVA). The Tukey’s test was used for multiple
comparisons of the means. The significance level was set at
P < 0.05.
4. Results and discussion
4.1. Binding affinity between catechins and human plasma
proteins
The binding affinities of catechins (EGCG, EC, EGC, Fig. 1) for
HSA and HH were assessed by the ability of these phyto-
chemicals to quench the intrinsic fluorescence of Trp. The
fluorescence intensity of the experimental units containing
HSA and HH gradually decreased with increasing concen-
trations of all tested tea catechins. The fluorescence quenching
data were computed for calculating the bimolecular quenching
constants (Kq) and the binding constants (Kb) of EC, EGC and
EGCG associated with each of the human plasma proteins
under study. As reported in Table 1, the Kq values in all tested
systems are higher than the diffusion-controlled rate constant
of the biomolecules (Kdiff = 1.0 × 10
10 L mol−1 s−1) which con-
firmed that the static quenching mechanism of the catechins
is the main reason behind the loss of intrinsic protein
fluorescence. The chemistry of this interaction usually involves
the reaction of the hydroxyl group with the carboxyl residues
of the protein to form hydrogen bonds. As a result of this reac-
tion, the di-hydroxyl moiety of a polyphenol is readily oxidized
to an orthoquinone, and then the quinine forms a dimer in a
side reaction, or reacts with amino or sulfhydryl side chains of
polypeptides to form covalent C\N or C\S bonds with the
phenolic ring, with the regeneration of the hydroquinone.20
This molecular interaction may alter the microenvironment of
the Trp-214 residue in HSA and the Trp-37 residue in the
β-subunit in HH which have been reported to be responsible
for the fluorescence emitted by both human plasma
proteins.21
Regarding the differences between experimental units, the
highest quenching rate constant in HSA solutions was
found for EGCG (15.30 × 1012 M−1 s−1) followed by EC (3.51 ×
1012 M−1 s−1) and EGC (1.43 × 1012 M−1 s−1). Consistently, the
strongest binding affinity for the same complexes followed the
decreasing order 5.81 × 104 L mol−1, 1.40 × 104 L mol−1 and
0.60 × 104 L mol−1, for EGCG, EC and EGC respectively. These
Fig. 1 Structures of the catechins tested in the present study. EC:
(−)-epicatechin; EGC: (−)-epigallocatechin; EGCG: (−)-epigallocatechin-
3-gallate.
Table 1 The bimolecular quenching rate constants (Kq; ×10
12 M−1 s−1)
and binding constants (Kb; ×10
4 L mol−1) between the catechins species
and the serum human proteins tested
HSA HH
Kq Kb Kq Kb
EC 3.51 1.40 1.02 0.37
EGC 1.43 0.60 0.58 0.24
EGCG 15.30 5.81 3.63 1.53
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values are comparable with those reported by Trnková et al.17
who analyzed the interaction mechanisms between these phy-
tochemicals and HSA using a similar spectroscopic approach.
The structural properties of the tea polyphenols largely explain
the binding affinities of these phytochemicals for plasma pro-
teins.20,22 In particular, the hydroxyl groups are known to play
a key role in these interactions as hydroxylation of phenolic
rings leads to an increase of the binding sites.22 The higher
ability of EGCG to bind to both human plasma proteins may
be explained by the presence of the galloyl moiety on the
C-ring of this catechin.22 In addition, the catechin with a cate-
chol group on the B-ring (EC) had a stronger binding affinity
than the species with a pyrogallol group (EGC).20 By applying
an HPLC analysis with an immobilized HSA column, Ishii
et al.16 studied the binding affinities of green tea catechins for
HSA and reported that the most important structural element
contributing to the HSA binding of tea catechins is the galloyl
group, followed by the number of hydroxyl groups on the
B-ring and the galloyl group or the configuration at C-2. Apply-
ing Fourier Transform Infrared (FTIR) methodologies and
docking studies, Maiti et al.23 provided substantial insight into
the molecular interaction between EGCG and HSA. In addition
to the confirmed strong affinity between both molecules, the
authors also reported that van der Waals interactions and
hydrogen bonding are primarily responsible for the overall
negative −G° of the reaction and also that the red shift in the
fluorescence spectra of HSA in the presence of EGCG (also
observed in the present study) is due to an increased polar
environment in the Trp-214 residue in HSA.
While the quenching rate constants between the catechins
and HH followed a similar order with EGCG (3.63 × 1012 M−1
s−1) showing the highest quenching potential followed by EC
(1.02 × 1012 M−1 s−1) and EGC (0.58 × 1012 M−1 s−1) the values
were lower as compared to those found for HSA. The binging
affinities of the catechins for HH were in good agreement with
their quenching abilities (1.53 × 104 L mol−1, 0.37 × 104 L
mol−1, 0.24 × 104 L mol−1, for EGCG, EC and EGC, respecti-
vely). The differences in binding affinities of catechins for
different proteins could be explained by several factors, includ-
ing their hydrophobicity, isoelectric point and amino acid
composition.24 HH has been much less studied than HSA for
its molecular interactions with polyphenols. According to a
study carried out by Xiao et al.25 in bovine hemoglobin (BH),
the affinities of flavonoids for this protein increased with an
increasing partition coefficient which meant that the binding
interaction between polyphenols and BH was mainly caused
by hydrophobic forces. BH as well as HH is a highly polar
macromolecule consisting of large numbers of amino,
hydroxyl, and carboxylic residues. The results from the present
study and the differences in binding affinities between tea
catechins and HH are in general consistent with the data
reported by Xiao et al.25 for BH.
Unlike the aforementioned studies, the concentration
range of the tea catechins in the present experimental units
was adjusted to that reported to occur in the plasma of
human individuals after tea consumption.14,15 Hence, the
present results confirm the intense affinity and molecular
interactions between human plasma proteins and these three
species under conditions closer to a realistic physiological
situation.
The reactions between polyphenols and plasma proteins
have attracted great interest owing to the consequences of
such interactions. Binding polyphenols not only affect the
structure and conformation of HSA as demonstrated by Maiti
et al.;23 the functionality of the protein and relevant physiologi-
cal processes may also be affected. For instance, the
distribution, metabolism, and efficacy of many drugs are
correlated with their affinities toward both HSA and HH. In
the present study, the consequences of these molecular
interactions were further investigated for the radical
scavenging activity of both the proteins and the catechins and
the potential protection of the latter against the glucose-
mediated carbonylation of the former.
4.2. In vitro antioxidant activity of catechins and human
proteins
Table 2 shows the values of percent inhibition against DPPH
of the experimental units containing each of the tea catechins
and human proteins alone, and the combination of them
(2 proteins × 3 tea catechins). The three catechins displayed, at
the tested concentrations, a radical scavenging capacity
against DPPH that ranged between 13.95 and 18.85%. These
results are in general concurrence with that obtained by Nanjo
et al.26 who reported that tea catechins and their epimers
showed 50% radical scavenging ability in the concentration
range of 1 to 3 µM. However, the differences found among
catechins for their antiradical activity diverge from those
reported by previous researchers who stated that the anti-
oxidant activity of tea was mainly attributed to the esterified
catechins (EGCG/ECG).26,27 Using Electron Spin Resonance
(ESR) measurements, Guo et al.27 confirmed that the presence
of a gallate group at the 3 position played the most important
role in their abilities to scavenge free radicals. They also
reported that the scavenging capacity of EGC was higher
than that of EC, suggesting that the presence of a hydroxyl
group at the 5′ position also played an important role in their
ability to scavenge free radicals. It is worth mentioning that
Table 2 Percent inhibition against the DPPH radical of HSA, HH (20 mg
mL−1), EC (0.7 µM), EGC (1.8 µM), and EGCG (0.7 µM) and the combi-
nation of all of them
19.92x,a ± 0.10 17.38y,a ± 0.12
HSA HH
18.85x,a ± 0.10 EC 18.05y,c ± 0.10 17.38z,a ± 0.19
13.95z,c ± 0.18 EGC 18.48x,b ± 0.12 17.01y,b ± 0.13
14.44x,b ± 0.26 EGCG 12.09d,z ± 0.11 13.10c,y ± 0.11
a,b,cMeans with different superscripts within a column were
significantly different in ANOVA. x,y,zMeans with different superscripts
within a row were significantly different in ANOVA.
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the concentration of the catechins as well as the ratio of
catechin/DPPH is considerably lower in the present study
compared to the aforementioned work and this factor is highly
influential in the outcome of this in vitro assay.28 The bulky
steric hindrance of catechins containing galloyl groups has
been reported to obstruct their DPPH scavenging activities27
and this condition may have played a major role at lower
concentrations of the catechins used in this study.
On the other hand, both human plasma proteins displayed
antioxidant capacity against DPPH and this capacity was com-
parable with that shown by the tea catechins (Table 2). Though
the scavenging activity of HH was in the range of all bio-
molecules tested, it was significantly lower than that of HSA.
The antioxidant properties of HSA are well-documented and
considered to be responsible for several important physiologi-
cal and pharmacological functions.29 The two sulfur-contain-
ing residues in HSA, Met and Cys, have been reported to
account for 40–80% of the total antioxidant activity of the
protein and more than 70% of the free radical-trapping activity
in serum.30 Again, the antioxidant capacity of HH is less
documented than that of HSA while recent reports identified
the β93 cysteine residue as a major contributor of its radical-
scavenging property and a relevant element of vascular anti-
inflammatory defense.31
The radical scavenging activities of the experimental units
combining catechins and human plasma proteins were lower
than the activities displayed by the individual elements
(Table 2). This finding may indicate that the polyphenol–
protein molecular interactions inhibit the antioxidant capacity
of the whole system (Table 2). The binding affinity of the cate-
chins for the human proteins seemed to play a role in the anti-
oxidant capacity of the experimental units with both
biomolecules. The scavenging activity of EGCG and EC
decreased in the presence of HSA and HH while the activity of
EGC, which showed a lower binding affinity for the proteins,
increased. Cao et al.32 also found that the DPPH scavenging
percentages of polyphenols decreased with increasing
affinities for bovine serum albumin (BSA). On the one hand,
the scavenging activity of plasma proteins, highly dependent
on the free thiols, may be lost as a result of the nucleophilic
addition of such protein residues with quinones.33 The
depletion of free thiols is a common consequence of the
covalent binding of phenolics to protein residues.34 Bae et al.35
reported that the incubation of EGCG with HSA occurred
along with the loss on a free sulfhydryl group in HSA which
supports the present hypothesis. As already explained, the
nucleophilic addition leads to the regeneration of the hydro-
quinone which may display antioxidant properties due to the
presence of hydroxyl groups.20 While, according to the present
results, the antioxidant potential of the protein-bound
catechin may be lower than that of the free catechin, the
former may exert efficient protection against the radical-
mediated oxidation of neighboring protein residues. Almajano
et al.36 came to similar conclusions while testing the radical
scavenging of adducts formed by EGCG and assorted plasma
and dairy proteins.
4.3. In vitro glycation of HSA and HH: tryptophan depletion
and formation of carbonyls and AGEs
The chemical modifications induced in HSA and HH as a
result of the incubation (10 days per 37 °C) with glucose
(12 mM) and iron (0.2 mM) are depicted in Fig. 2. The glyca-
tion of HSA has been typically linked to Maillard-mediated
mechanisms that proceed via the attachment of a glucose
molecule to N-terminal residues or the ε-amino group of
protein-bound lysine residues, resulting in the formation of
reversible Schiff bases. These adducts are in equilibrium with
the glucose in solution and with their rearranged Amadori pro-
ducts that may subsequently undergo irreversible rearrange-
ment to form fluorescent AGEs.7 However, glucose can actually
undergo metal-catalyzed oxidation that leads to the production
of ketoaldehydes, hydrogen peroxide and other highly reactive
Fig. 2 Evolution of TRP concentration (A), carbonyl content (B) and
pentosidine fluorescence (C) during incubation of HSA and HH solutions
(20 mg mL−1) for 10 days at 37 °C with glucose (12 mM) and iron
(0.2 mM).
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oxidants.8 Furthermore, Hedegaard et al.37 recently reported
the formation of reactive oxygen species during the incubation
of β-lactoglobulin with glucose (1 M) and Fe2+ (5 mM) and the
subsequent radical-mediated oxidation of the protein. While
the experimental conditions of this latter experiment are con-
siderably severe, simulated physiological conditions like those
applied in the present study have also been found to generate
reactive carbonyls and ROS from glucose autoxidation.8 Hence,
the chemical damage to the present human plasma proteins
could be reasonably attributed to the pro-oxidant action of
species formed from ‘autoxidative glycosylation’ reactions.
Tryptophan is highly sensitive to ROS and its depletion is
considered an early expression of the oxidative damage to pro-
teins. The initial Trp concentrations in HH and HSA solutions
decreased throughout the incubation assay with this depletion
being more remarkable in HH due to the initial larger concen-
tration of this amino acid (Fig. 2A). At the end of the assay,
HSA and HH lose 63 and 80% of the initial Trp, respectively.
Similar Trp depletions were recorded by Khan et al.38 inducing
an in vitro glycation of HSA for up to 20 weeks in the absence
of metals. The metal-catalyzed oxidation of glucose may defi-
nitely accelerate the loss of Trp as Coussons et al.39 observed a
dramatic Trp loss in HSA when Cu2+ (50 µM) was added to the
glucose-induced (5–50 mM) glycation assay. In the absence of
the metal, the loss of Trp was negligible even at high glucose
concentrations (500 mM) and prolonged incubation periods at
37 °C (56 days). It can be hypothesized whether the decrease
in the fluorescence of the tryptophanyl residues was caused by
a glycation-dependent conformational change within the
protein that affected the local environment of Trp. However,
whenever pro-oxidative species are present (i.e. glucose is com-
bined with transition metals) the loss of Trp is promoted plau-
sibly via free radical mechanisms.8 The present results
illustrate the high susceptibility of HH to glucose-mediated
degradation as previously reported by Cussimanio et al.40 Trp
is particularly susceptible as glycated HH has been found to
undergo structural modifications leading to an exposure of Trp
residues41 that may be readily oxidized by glucose-mediated
ROS. This is a relevant finding owing to the biological signifi-
cance of Trp oxidation in a hyperglycemic environment.42 The
recurrent observation of low Trp levels in the plasma of diabetic
patients may be caused by the molecular mechanisms
described here and this may lead to further disorders such as
enzyme malfunction and neurological complications.43
The formation of specific carbonyls, AAS and GGS, occurred
in both plasma proteins during incubation (Fig. 2B). After 10
days, the concentration of carbonyls significantly increased
from 0.24 to 2.03 in HSA and from 0.44 to 1.85 nmol mg−1
protein in HH. The carbonylation of human plasma proteins
under hyperglycemic conditions, including that which
occurred in diabetic patients, has been profusely documen-
ted.10,38,41,44 However, this analysis is commonly made using
unspecific methods for the detection of protein hydrazones
upon DNPH derivatization while the exact nature of the carbo-
nyl species as well as the underlying chemical pathways were
not described. In fact, to the best of our knowledge, this study
reports original data on the concentration of AAS and GGS in
human plasma proteins incubated under simulated physio-
logical conditions. Before us, only Akagawa et al.9 reported
elevated levels of both protein carbonyls in diabetic rats. The
same authors5 proved the in vitro formation of these semialde-
hydes in BSA in the presence of glucose-derived α-dicarbonyls
(2 mM glyoxal and methylglyoxal), confirming the occurrence
of ‘autoxidative glycosylation’ mechanisms in the oxidative
damage to glycated proteins. The Maillard-mediated mechan-
ism has been thoroughly described elsewhere.5,6 These highly
reactive dicarbonyls may condense with the є-amino group
from the side chains of lysine, arginine and proline causing
oxidative deamination and the subsequent formation of the
carbonyl moiety in the side chain of the susceptible amino
acid. Taking into consideration the proven generation of ROS
as a result of the metal-catalyzed oxidation of glucose, the for-
mation of AAS and GGS via a direct attack of free radicals on
alkaline amino acids could plausibly have happened. In fact,
the formation of both carbonyls in plasma and muscle pro-
teins has been induced in vitro by hydroxyl-radical generating
systems.5,45 Hence, protein glycation and protein oxidation are
inextricably linked as two different pathways lead to the for-
mation of the same product and under the conditions of the
present experiment, the contribution of each mechanism to
carbonyl formation is indistinguishable.
The concentration of carbonyls (AAS + GGS) in HSA and HH
after 10 days of incubation at 37 °C in the presence of glucose
(12 mM) and Fe3+ (200 µM) in the present study, is in the
range reported by Akagawa et al.5 in BSA and in line with the
extent of protein carbonylation found in diabetic
patients.10,46,47 Both proteins behaved similarly in their sus-
ceptibility to carbonylation though HH suffered a more
intense damage at an intermediate sampling (day 6) (Fig. 2B).
Carbonylation may have progressed faster in this protein owing
to the reported effect of glycosylation on the release of heme
iron from HH that enhances, in turn, further oxidative damage
including Trp depletion and carbonylation.44 The carbonylation
level was similar between proteins at the end of the assay as a
likely consequence of the total consumption of glucose (data
not shown), that could have acted as a limiting factor.
Finally, and as expected, the incubation of human proteins
with glucose and Fe3+ led to an increase in pentosidine
(Fig. 2C). This AGE is a potent protein-crosslinking agent typi-
cally formed in glycosylation reactions between proteins and
reducing sugars. Using specific anti-radical agents, Khan
et al.38 were able to block the formation of pentosidine in HSA
treated with 0.05 M glucose, incriminating the hydroxyl and
superoxide radicals in pentosidine formation. The behavior of
the plasma proteins in the present study is consistent with
that reported previously.38–40 The pentosidine specific fluo-
rescence was more intense in HSA and the increase observed
during the last stage of incubation enlarged the differences
between proteins. This remarkable difference between HSA
and HH may be due to the presence and availability of lysine
and arginine residues on the surface of the protein as
both amino acids are involved in pentosidine formation.
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Pentosidine is used as a marker of diseases and commonly
used as an indicator of diabetes complications such as hyper-
tension, heart failure and retinopathy.48
4.4. Effect of catechins against human protein glycation
Owing to the close connection between glycosylation and
oxidative stress in hyperglycemia and diabetes, diverse plant
materials with antioxidant potential have recently been tested
as natural remedies for alleviating the symptoms of the
metabolic syndrome.11,44,49 In most of these studies, however,
the chemistry behind the interaction of the phytochemicals in
particular biomolecules remains unknown. In particular, the
understanding of the impact of these catechins on the
oxidative stability of human proteins is critical owing to the
biological significance of protein oxidation in these metabolic
disorders. The ability of tea catechins at postprandial concen-
trations in plasma to inhibit the glucose-mediated oxidative
damage to human plasma proteins was assessed and the
results are displayed in Fig. 3–5.
Catechins fully inhibited Trp degradation as the concen-
tration of Trp in the experimental units treated with the cate-
chins did not vary during incubation (p > 0.05) (data not
shown). The effectiveness of the catechins against Trp
oxidation, as assessed by the remaining Trp, was similar in
the experimental units with HSA (Fig. 3A) while significant
Fig. 3 Remaining Trp concentration in HSA (A) and HH (B) solutions
(20 mg mL−1) after incubation for 10 days at 37 °C with glucose (12 mM),
iron (0.2 mM) and, when denoted, with EC (0.7 µM), EGC (1.8 µM), and
EGCG (0.7 µM). a,b,cDifferent letters on the top of bars denote significant
differences between treatments.
Fig. 4 Concentration of carbonyls (AAS + GGS) in HSA (A) and HH (B)
solutions (20 mg mL−1) incubated for 10 days at 37 °C with glucose
(12 mM), iron (0.2 mM) and, when denoted, with EC (0.7 µM), EGC
(1.8 µM), and EGCG (0.7 µM). a,b,cDifferent letters on the top of bars
denote significant differences between treatments.
Fig. 5 Pentosidine fluorescence in HSA (A) and HH (B) solutions (20 mg
mL−1) incubated for 10 days at 37 °C with glucose (12 mM), iron
(0.2 mM) and, when denoted, with EC (0.7 µM), EGC (1.8 µM), and EGCG
(0.7 µM). a,b,cDifferent letters on the top of bars denote significant differ-
ences between treatments.
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differences were found in HH (Fig. 3B). HH solutions with EC
had a significantly higher remaining Trp than solutions con-
taining EGCG while EGC was in an intermediate position.
Catechins also protected plasma proteins against glucose-
mediated carbonylation (Fig. 4). While the three catechins
under study reduced the protein carbonyls in HH to a similar
extent (Fig. 4B), significant differences were found between
catechins in their ability to control carbonylation of HSA
(Fig. 4A). EGC displayed more intense protection against HSA
carbonylation followed by EC and EGCG. Anyway, the percent
inhibitions against HSA carbonylation were beyond the 80%
for the three catechins. The protection of the tested catechins
against the glycation of HH was not reflected in the formation
of pentosidine (Fig. 5). Compared to HH, HSA suffered a more
intense pentosidine formation and in this case a significant
protective effect of catechins was observed and followed the
decreasing order EGCG > EC > EGC (Fig. 5A).
The antioxidant activity of catechins is generally attributed
to their ability to chelate metals and scavenge free radicals26
with any of these two mechanisms being applicable to the
present results. The protection of catechins on plasma pro-
teins has been previously documented, including both oxi-
dative (radical-mediated) and glycosylative stress.50 However,
the outstanding ability of the three catechins at such low plas-
matic concentrations to inhibit Trp oxidation and AAS/GGS
formation in HH and HSA has no precedent in the literature.
The results obtained for the effect of catechins on
carbonylation and pentosidine suggest a likely connection
between the affinity of the phytochemicals to bind to the pro-
teins and their ability to protect against the glucose-mediated
oxidative damage. The effect of catechins against carbonyla-
tion was inversely related to their ability to bind to proteins,
which suggests a more intense activity of the free species. In
contrast, binding to the protein seemed to be linked to the
ability to protect against pentosidine formation. This is
reasonable as in addition to their antioxidant activities,
attached phenolics may exert some steric hindrance to the for-
mation of cross-links between intra- or intermolecular protein
residues. The fact that such effects were only observed in HSA,
for which catechins had a higher affinity, provides some
strength to this hypothesis.
The present results provide an approximate picture of the
beneficial effects that tea consumption may have against the
glycosylation of HSA and HH at a pathological glucose concen-
tration (∼12 mM). It is worth noting that physiological studies
report the presence of both free and conjugated forms of the
three catechins in the bloodstream upon tea consumption.14,15
The protective effects reported in the present study may only
be applicable to the free forms. The consequences of this pro-
tection are of biological significance since the oxidative degra-
dation of plasma proteins reflects the damage that oxidative
stress may cause in living cells and tissues.3 Glycation-modi-
fied hemoglobin in particular, has been suggested to be a
source of enhanced catalytic iron and free radicals causing
pathological complications in diabetes mellitus.44 On this
line, Roy et al.44 found that dietary pelargonidin protected
against glucose-mediated HH oxidation leading to an overall
amelioration of oxidative stress linked to hyperglycemia.
Regarding specific molecular changes, the loss of Trp and the
formation of carbonyls in particular, have been found to play a
role in the pathogenesis of diabetes, the metabolic syndrome
and other disorders caused by oxidative stress.3 Chetyrkin
et al.42 originally reported on the relationship between the oxi-
dation of tryptophan and the altered function of proteins
under hyperglycemic conditions. In response to this relevant
finding, Jain43 hypothesized (i) whether this would explain the
reduced plasmatic levels of Trp in Type II diabetic patients and
(ii) if this impairment may be neutralized by inhibitors of
glycol-oxidative reactions. As long as the present results could
be confirmed in an in vivo system, catechins may provide
means to alleviate plasmatic Trp depletion under hyperglyce-
mic conditions and hence, control the serious consequences
linked to such a disorder.42 Protein carbonyls and pentosidine,
on the other side, have been recurrently described as stable
markers of multiple metabolic disorders including Type II dia-
betes.3 Interestingly, a recent report51 highlighted α-amino
adipic acid (AAA), the oxidation end-product of AAS, as the
most reliable early indicator of diabetes risk in humans. The
authors also found that AAA could modulate the function of
endocrine pancreas and induce diabetes in experimental
animals fed the aforementioned compound. As long as lysine
oxidation/glycation products play a role as signaling molecules
or are even involved in the pathogenesis of metabolic
disorders, tea catechins may contribute to normalizing a
homeostatic situation by inhibiting carbonylation of plasma
proteins.
5. Conclusion
Protein carbonyls (AAS and GGS) may be used as reliable and
specific markers of the oxidative damage caused to human
plasma proteins under hyperglycemic conditions. The trp
depletion reported in plasma from diabetic patients may be
explained by the molecular mechanisms reported in the
present paper. Three major tea catechins were able to efficien-
tly inhibit the oxidative damage to human hemoglobin and
HSA at postprandial blood concentrations. It is of note that an
impaired oxidative status is thought to be responsible for the
metabolic syndrome and further health complications in dia-
betic patients. These results emphasize the beneficial effects
of tea catechins against the impairment of glucose metabolism
in human individuals. The present results provide scientific
evidence for the control of the oxidative stress linked to hyper-
glycemia through dietary tea catechins.
Abbreviation
HSA Human serum albumin
HH Human hemoglobin
BSA Bovine serum albumin
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EC (−)-Epicatechin
EGC (−)-Epigallocatechin
EGCG (−)-Epigallocatechin-3-gallate
Trp Tryptophan
AAA α-Aminoadipic acid
AAS α-Aminoadipic semialdehyde
GGS γ-Glutamic semialdehyde
AGEs Advanced glycation end products
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